Don’t destroy future drug development

8 December 2021 - With support faltering for the massive big-government blowout Congress is trying to jam through by Christmas, ...

Read more →

New therapies for a range of conditions are coming in 2022

8 December 2021 - Haemophilia, brain disorders and malaria are being targeted. ...

Read more →

Competing with, and learning from, China in the global pharmaceutical innovation race

15 November 2021 - President Joe Biden has promoted investment in technology based industries, including the life sciences, as a strategic ...

Read more →

Regulating drug prices while increasing innovation

13 November 2021 - To save money on drugs while encouraging high-value pharmaceutical innovation, we need to better reward value, increase ...

Read more →

FDA, NIH and 15 private organisations join forces to increase effective gene therapies for rare diseases

27 October 2021 - The U.S. FDA, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organisations have partnered ...

Read more →

Why we can have both innovative drugs and lower drug prices

13 October 2021 - The debate in Congress over negotiating drug prices is based on a phony premise that higher prices ...

Read more →

Tegsedi receives innovative drug category pricing in Brazil

11 October 2021 - PTC Therapeutics today announced that Tegsedi (inotersen) has successfully received Category 1 classification from Câmara de ...

Read more →

Medicare drug pricing debate pits savings against innovation

11 October 2021 - Proposal to allow Medicare to negotiate for lower prescription drug prices is central to Democrats’ health care, ...

Read more →

Biden drug pricing plan seeks to balance access and innovation

13 September 2021 - On Thursday 9 September, Health and Human Services Secretary Xavier Becerra publicly released the Biden Administration’s ...

Read more →

Pharmaceutical companies should pay for raiding nature's medicine cabinet

11 August 2021 - In 2019, the pharmaceutical industry profited from US$1·2 trillion of global spending on medicines. Most of this ...

Read more →

Making pharmaceutical companies report what matters about innovation

29 July 2021 - There is a lack of transparency about the cost of innovation of the pharmaceutical industry even ...

Read more →

NHS England unveils new Innovative Medicine Fund

21 July 2021 - NHS England has unveiled its new Innovative Medicines Fund, to ensure patients have early access to ...

Read more →

Teplizumab awarded Innovation Passport in the United Kingdom for the delay of onset of clinical type 1 diabetes in at risk individuals

12 July 2021 - Designation is the first step in a new MHRA initiative to accelerate the development and access to ...

Read more →

Most Americans support Medicare negotiation despite claims it would hurt innovation

3 June 2021 - A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support ...

Read more →

Making cancer treatments affordable today won’t hurt tomorrow’s innovation

12 May 2021 - Congress is about to debate legislation—the Lower Drug Costs Now Act (H.R.3)—that would give Medicare the ...

Read more →